Do you want to read an article? Please log in or register.
Olaparib Monotherapy as Primary Treatment in Unselected Triple Negative Breast Cancer
Breast Cancer
Related content
Breast Cancer
Recent Developments in Metastatic Breast Cancer
healthbook TIMES Oncology Hematology
RECOMMENDED
Breast Cancer
Pembrolizumab for Early Triple-Negative Breast Cancer
★ 2
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
doi: 10.1056/NEJMoa1910549.
RECOMMENDED
Breast Cancer
Adjuvant chemotherapy in small node-negative triple-negative breast cancer
★ 1
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
Eur J Cancer.
Steenbruggen TG, van Werkhoven E, van Ramshorst MS, Dezentjé VO, Kok M, Linn SC, Siesling S, Sonke GS
doi: 10.1016/j.ejca.2020.04.033.
Breast Cancer
De-escalating and Escalating Treatments for Early Stage Breast Cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
Ann Oncol 2017
Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart G, Senn HJ, Thürlimann B, on behalf of the Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017,
André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Hussein K, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B
doi: 10.1093/annonc/mdx308.
SPECIAL REPORT
Breast Cancer
Olaparib confers benefit in metastatic breast cancer
doi: 10.1093/annonc/mdz012. [Epub ahead of print].
Breast Cancer
Addition of chemotherapy to local therapy in women aged 70 years or older with triple-negative breast cancer: a propensity-matched analysis
Lancet Oncol.
Crozier JA, Pezzi TA, Hodge C, Janeva S, Lesnikoski BA, Samiian L, Devereaux A, Hammond W, Audisio RA, Pezzi CM
doi: 10.1016/S1470-2045(20)30538-6.
Breast Cancer
Breast Cancer Treatment in the Era of Precision Medicine
1Breast Cancer Center, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland
Breast Cancer
BRCA1/2-negative hereditary triple-negative breast cancers exhibit BRCAness
Int J Cancer.
Domagala P, Hybiak J, Cybulski C, Lubinski J
doi: 10.1002/ijc.30570
Breast Cancer
Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer
Eur J Cancer.
Salvador-Coloma C, Santaballa A, Sanmartín E, Calvo D, García A, Hervás D, Cordón L, Quintas G, Ripoll F, Panadero J, Font de Mora J
doi: 10.1016/j.ejca.2020.08.020.